'A global outlier': how drug firms are fighting back against

The Pharmaceutical Journal from the Royal Pharmaceutical Society

Related Keywords

Ireland , United Kingdom , British , Olivier Wouters , Eli Lilly , Laura Steele , Mark Sculpher , Hugh Taylor , David Watson , Jessamy Baird , Haran Maheson , University Of York Centre For Health Economics , Gilead Sciences United Kingdom , London School Of Economics , Branded Health Service Medicines Costs Regulations , British Generic Manufacturers Association , Department Of Health , Association Of The British Pharmaceutical Industry , National Institute For Health , Services Negotiating Committee , Voluntary Scheme , Branded Medicines Pricing , British Pharmaceutical Industry , Branded Health Service Medicines , Northern Europe , Pharmaceutical Journal , United Kingdom Based , Sanofi United Kingdom , Mike Dent , Pharmaceutical Services Negotiating Committee , National Institute , Care Excellence , Bayer United , London School , Social Care , Health Economics ,